| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |